Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis - Scorecard - MDSpire

Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis

  • By

  • Zechang Xin

  • Xiaoyu Zhu

  • Hui Qu

  • Xing Ai

  • Kaixuan Wang

  • Xinyue Li

  • Ming Wang

  • Pisong Li

  • Zhongbin Han

  • Ningxin Qu

  • Weiting Yu

  • Hongshen Chen

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Cardiometabolic Risk Factors Prior to Treatment in Newly Diagnosed Breast Cancer: An Analysis by Molecular Subtype

At a Glance

CategoryDetail
Condition
Key MechanismsDyslipidemia and cardiovascular comorbidities associated with tumor features and molecular subtypes.
Target Population
Care Setting

Key Highlights

  • Lymph node metastasis correlated with dyslipidemia only in Luminal B subtypes, requiring further clarification.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider subtype-specific factors in treatment planning, including tailored cardiovascular risk management.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        5,246 Chinese women with newly diagnosed breast cancer.

        Data collected before initiation of any anticancer therapy.

        Clinical Best Practices

        • Assess cardiovascular comorbidities and lipid profiles at the time of breast cancer diagnosis, with subtype-specific considerations.

        Related Resources & Content

        Original Source(s)

        Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis

        • by Zechang Xin, Xiaoyu Zhu, Hui Qu, Xing Ai, Kaixuan Wang, Xinyue Li, Ming Wang, Pisong Li, Zhongbin Han, Ningxin Qu, Weiting Yu, Hongshen Chen

        • June 10, 2026

        Related Content

        Early identification of neoadjuvant therapy non-response via multimodal immune-imaging biomarkers in breast cancer

        RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression

        Depression and breast cancer: research progress and prospects from an interdisciplinary perspective